LSB News

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

BEIJING, Aug. 28, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for...

August 28, 2025Mergers

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

LSB

BEIJING, Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for...

August 18, 2025Mergers

LakeShore Biopharma Announces Official Launch of Novel Packaging Solution for YSJA Rabies Vaccine

LSB

April 23, 2025

LakeShore Biopharma Sees FY25 Revenues To Be Between RMB 665 Million - RMB 700 Million, Indicating Growth Of 16%-22% YoY

LSB

December 19, 2024

LakeShore Biopharma H1 2025 EPS $0.02; Revenue $53.08M

LSB

December 19, 2024